Sep 2026
C-reactive protein-to-albumin ratio predicts survival in hepatocellular carcinoma on atezolizumab plus bevacizumab.
Mayumi Ehara, Toshifumi Tada, A. Morii et al.
· Oncology · 0 citations
1 paper indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.